search
Back to results

The Performance of the SOLTIVE Laser System for Laser Lithotripsy in Kidney or Ureteral Stones

Primary Purpose

Kidney Stone, Ureteral Stone

Status
Active
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
SOLTIVE™ Premium SuperPulsed Laser Fiber System
Sponsored by
Olympus Corporation of the Americas
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Kidney Stone

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. ≥18 years of age
  2. Medical indication for ureteroscopy, percutaneous nephrolithotomy (PCNL) or mini PCNL
  3. Willing and able to provide informed consent
  4. Female and of childbearing age with a negative pregnancy test

Exclusion Criteria:

  1. Contraindicated for uteroscopy, PCNL or mini PCNL as determined by the physician
  2. Inability to tolerate anesthesia for any reason
  3. Unable or unwilling to provide informed consent
  4. Concurrently participating in another competing clinical study
  5. Known ureteral stricture
  6. Unwilling or unable to return for follow-up

Sites / Locations

  • Mayo Clinic Arizona
  • Loma Linda University Medical Center
  • Kansas University Medical Center
  • Mount Sinai West
  • Ohio State Wexner Medical Center
  • University Southern Denmark
  • Hospital CUF Descobertas

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Thulium Fiber Laser lithotripsy

Arm Description

Subjects who have a medical indication for ureteroscopy, percutaneous nephrolithotomy (PCNL) or mini PCNL

Outcomes

Primary Outcome Measures

Stone free rate
Stone free rate as determined by standard of care imaging

Secondary Outcome Measures

Total laser energy time
Measured from first to last footswitch press in minutes
Total procedure time
Measured from time of initial ureteroscope insertion to time of ureteroscope withdrawal in minutes
Accessory devices used
Types of accessory devices used during the procedure (ureteroscopy, PCNL or mini-PCNL) and the total time used during the procedure in minutes
Adverse events
AEs related to device or procedure and non-serious AEs related to device or procedure
Device deficiencies
Number of device deficiencies during the procedure
Rate of treatment/interventions needed
Types of treatments and/or interventions needed post-procedure at the follow-up visits and the number of times treatments and/or interventions were performed

Full Information

First Posted
September 7, 2020
Last Updated
February 8, 2023
Sponsor
Olympus Corporation of the Americas
search

1. Study Identification

Unique Protocol Identification Number
NCT04556201
Brief Title
The Performance of the SOLTIVE Laser System for Laser Lithotripsy in Kidney or Ureteral Stones
Official Title
A Prospective, Multicenter, Post-Market Clinical Registry to Collect Real-World Evidence on the Clinical Performance of the SOLTIVE™ Laser for Treatment of Kidney or Ureteral Stones
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
December 1, 2020 (Actual)
Primary Completion Date
February 2, 2023 (Actual)
Study Completion Date
May 2, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Olympus Corporation of the Americas

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to collect real-world evidence on the performance of the SOLTIVE™ Premium SuperPulsed Laser System for laser lithotripsy in ureteroscopy, percutaneous nephrolithotomy (PCNL) and mini PCNL for kidney and ureteral stones.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Kidney Stone, Ureteral Stone

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
450 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Thulium Fiber Laser lithotripsy
Arm Type
Experimental
Arm Description
Subjects who have a medical indication for ureteroscopy, percutaneous nephrolithotomy (PCNL) or mini PCNL
Intervention Type
Device
Intervention Name(s)
SOLTIVE™ Premium SuperPulsed Laser Fiber System
Intervention Description
SOLTIVE™ SuperPulsed Laser Fiber System and SOLTIVE™ Laser Fibers for single-use only
Primary Outcome Measure Information:
Title
Stone free rate
Description
Stone free rate as determined by standard of care imaging
Time Frame
3 month
Secondary Outcome Measure Information:
Title
Total laser energy time
Description
Measured from first to last footswitch press in minutes
Time Frame
During procedure
Title
Total procedure time
Description
Measured from time of initial ureteroscope insertion to time of ureteroscope withdrawal in minutes
Time Frame
During procedure
Title
Accessory devices used
Description
Types of accessory devices used during the procedure (ureteroscopy, PCNL or mini-PCNL) and the total time used during the procedure in minutes
Time Frame
During procedure
Title
Adverse events
Description
AEs related to device or procedure and non-serious AEs related to device or procedure
Time Frame
At procedure, immediate post-procedure, 1 month follow-up and 3 month follow-up
Title
Device deficiencies
Description
Number of device deficiencies during the procedure
Time Frame
During procedure
Title
Rate of treatment/interventions needed
Description
Types of treatments and/or interventions needed post-procedure at the follow-up visits and the number of times treatments and/or interventions were performed
Time Frame
At 1 month follow-up and 3 month follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: ≥18 years of age Medical indication for ureteroscopy, percutaneous nephrolithotomy (PCNL) or mini PCNL Willing and able to provide informed consent Female and of childbearing age with a negative pregnancy test Exclusion Criteria: Contraindicated for uteroscopy, PCNL or mini PCNL as determined by the physician Inability to tolerate anesthesia for any reason Unable or unwilling to provide informed consent Concurrently participating in another competing clinical study Known ureteral stricture Unwilling or unable to return for follow-up
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ben Chew, MD
Organizational Affiliation
University of British Columbia
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Olivier Traxer, MD
Organizational Affiliation
Tenon Hospital, Sorbonne University, Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic Arizona
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85054
Country
United States
Facility Name
Loma Linda University Medical Center
City
Loma Linda
State/Province
California
ZIP/Postal Code
92354
Country
United States
Facility Name
Kansas University Medical Center
City
Kansas City
State/Province
Kansas
ZIP/Postal Code
66160
Country
United States
Facility Name
Mount Sinai West
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States
Facility Name
Ohio State Wexner Medical Center
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43212
Country
United States
Facility Name
University Southern Denmark
City
Fredericia
ZIP/Postal Code
7000
Country
Denmark
Facility Name
Hospital CUF Descobertas
City
Lisboa
ZIP/Postal Code
1998-018
Country
Portugal

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Subject data collected during the study after de-identification.
IPD Sharing Time Frame
Immediately following publication
Citations:
PubMed Identifier
28213860
Citation
Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World J Urol. 2017 Sep;35(9):1301-1320. doi: 10.1007/s00345-017-2008-6. Epub 2017 Feb 17.
Results Reference
result
PubMed Identifier
22498635
Citation
Scales CD Jr, Smith AC, Hanley JM, Saigal CS; Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012 Jul;62(1):160-5. doi: 10.1016/j.eururo.2012.03.052. Epub 2012 Mar 31.
Results Reference
result
Citation
C. Türk, A. Skolarikos, A. Neisius, A. Petrik, C. Seitz, K. Thomas, EAU Guidelines. European Association of Urology (EAU). 2019.
Results Reference
result
PubMed Identifier
27238616
Citation
Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, Pace KT, Pais VM Jr, Pearle MS, Preminger GM, Razvi H, Shah O, Matlaga BR. Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I. J Urol. 2016 Oct;196(4):1153-60. doi: 10.1016/j.juro.2016.05.090. Epub 2016 May 27.
Results Reference
result
PubMed Identifier
31476349
Citation
Aldoukhi AH, Knudsen BE, Black KM, Hall TL, Roberts WW, Ghani KR. Are We Cutting Ourselves Short? Laser Lithotripsy Performance Based on Differences in Fiber-tip Preparation. Urology. 2019 Dec;134:79-83. doi: 10.1016/j.urology.2019.08.027. Epub 2019 Aug 30.
Results Reference
result
Citation
Peter Kronenberg, Olivier Traxer. V1718 laser fibers, pulse energy and retropulsion- what we can see and what we can´t. ResearchGate. 2013.
Results Reference
result
PubMed Identifier
29253579
Citation
Humphreys MR, Shah OD, Monga M, Chang YH, Krambeck AE, Sur RL, Miller NL, Knudsen BE, Eisner BH, Matlaga BR, Chew BH. Dusting versus Basketing during Ureteroscopy-Which Technique is More Efficacious? A Prospective Multicenter Trial from the EDGE Research Consortium. J Urol. 2018 May;199(5):1272-1276. doi: 10.1016/j.juro.2017.11.126. Epub 2017 Dec 16.
Results Reference
result
PubMed Identifier
11743269
Citation
Sofer M, Watterson JD, Wollin TA, Nott L, Razvi H, Denstedt JD. Holmium:YAG laser lithotripsy for upper urinary tract calculi in 598 patients. J Urol. 2002 Jan;167(1):31-4. doi: 10.1016/s0022-5347(05)65376-1.
Results Reference
result
PubMed Identifier
21869908
Citation
Zarrabi A, Gross AJ. The evolution of lasers in urology. Ther Adv Urol. 2011 Apr;3(2):81-9. doi: 10.1177/1756287211400494.
Results Reference
result
PubMed Identifier
29774438
Citation
Kronenberg P, Somani B. Advances in Lasers for the Treatment of Stones-a Systematic Review. Curr Urol Rep. 2018 May 17;19(6):45. doi: 10.1007/s11934-018-0807-y.
Results Reference
result
PubMed Identifier
30729311
Citation
Traxer O, Keller EX. Thulium fiber laser: the new player for kidney stone treatment? A comparison with Holmium:YAG laser. World J Urol. 2020 Aug;38(8):1883-1894. doi: 10.1007/s00345-019-02654-5. Epub 2019 Feb 6.
Results Reference
result
Citation
Scott, N. J., C. M. Cilip, and N. M. Fried. Thulium Fiber Laser Ablation of Urinary Stones Through Small-Core Optical Fibers, IEEE Journal of Selected Topics in Quantum Electronics. 2009;(15):435-40.
Results Reference
result
PubMed Identifier
14667517
Citation
Pasqui F, Dubosq F, Tchala K, Tligui M, Gattegno B, Thibault P, Traxer O. Impact on active scope deflection and irrigation flow of all endoscopic working tools during flexible ureteroscopy. Eur Urol. 2004 Jan;45(1):58-64. doi: 10.1016/j.eururo.2003.08.013.
Results Reference
result
PubMed Identifier
25432821
Citation
Kronenberg P, Traxer O. The truth about laser fiber diameters. Urology. 2014 Dec;84(6):1301-7. doi: 10.1016/j.urology.2014.08.017.
Results Reference
result
PubMed Identifier
32742931
Citation
Mahmood SN, Toffeq H, Fakhralddin S. Sheathless and fluoroscopy-free retrograde intrarenal surgery: An attractive way of renal stone management in high-volume stone centers. Asian J Urol. 2020 Jul;7(3):309-317. doi: 10.1016/j.ajur.2019.07.003. Epub 2019 Jul 16.
Results Reference
result
PubMed Identifier
32108256
Citation
Enikeev D, Taratkin M, Klimov R, Alyaev Y, Rapoport L, Gazimiev M, Korolev D, Ali S, Akopyan G, Tsarichenko D, Markovina I, Ventimiglia E, Goryacheva E, Okhunov Z, Jefferson FA, Glybochko P, Traxer O. Thulium-fiber laser for lithotripsy: first clinical experience in percutaneous nephrolithotomy. World J Urol. 2020 Dec;38(12):3069-3074. doi: 10.1007/s00345-020-03134-x. Epub 2020 Feb 27.
Results Reference
result

Learn more about this trial

The Performance of the SOLTIVE Laser System for Laser Lithotripsy in Kidney or Ureteral Stones

We'll reach out to this number within 24 hrs